Glecaprevir and Pibrentasvir
Glecaprevir (a HCV NS3/4A protease inhibitor) and pibrentasvir (HCV NS5A phosphoprotein inhibitor) combination is used for the treatment of all genotypes (1-6) of chronic hepatitis C virus infection either without cirrhosis or with compensated early stage cirrhosis in adults.